"Lenvima" (lenvatinib) is a drug used to combat differentiated thyroid cancer, which is immune to traditional therapy with radioactive iodine. The active substance of the drug has an effect that blocks intracellular signals, due to which the development and division of cancer cells stops.
According to the results of studies, the use of the named tool helps to increase survival rates without the development of pathological processes.
Where can I buy Lenvima cheaper
Despite the fact that the drug was developed not so long ago, it is already recognized as one of the priority agents in the treatment of this pathology. But acquiring it for an ordinary patient can be difficult. In Moscow, for example, for Lenvima capsules, the price starts at 145,000 rubles. In such a situation, a well-proven site can come to the rescue. offering generics of famous anti-cancer drugs.
Speaking about generics, it should be emphasized that these funds are in no way inferior to branded ones, because they have the same formula. That is, the analogue will be as effective as the Lenvima drug itself. The price will be much lower, since, having acquired the right to issue, the company does not spend money on research and advertising.
Application features
Treatment with the drug is carried out only under the supervision of a specialist. Capsules "Lenvima" taken orally, once a day, without chewing and drinking water. There is no need to correlate the intake of the drug with the time of eating.
Patients are usually prescribed 24 mg per day. But the doses are adjusted depending on the condition of the patient. And in some cases, a temporary suspension of the drug is required. The duration of treatment is determined by the presence of clinical benefits from the use of the named funds.
Contraindications
The drug "Lenvima" is not prescribed for patients with hepatic and renal failure, pregnant women, as well as nursing and children under 18 years of age, as well as those who are predisposed to allergic reactions to the components of the drug.
Patients suffering from hypertension, having undergone surgery or radiation therapy, suffering from bradyarrhythmias or congestive heart failure, as well as people over 75 years of age, should use the drug "Lenvima" with caution.
Women taking this drug should be protected from pregnancy for at least a month after treatment is stopped.
Side effects
The use of the drug "Lenvima" can lead to the following side effects:
- urinary tract infections;
- inflammation of the oral cavity;
- the development of palmar-plantar syndrome;
- the appearance of edema;
- fatigue;
- asthenia;
- thrombocytopenia;
- decreased appetite;
- hypocalcemia;
- weight loss;
- hypokalemia;
- insomnia;
- headache;
- increase AD;
- back pain.
Since the use of Lenvima capsules (lenvatinib) can cause dizziness and fatigue in patients, they should be careful when working with moving mechanisms and while driving.